article thumbnail

Will Consumers Cross the Cost-and-Trust Chasm Between Prescription Drugs and Hospitals?

Health Populi

When asked what factors contribute to rising health care costs in America, most consumers cite the cost of prescription drugs. Taken together, these two data points demonstrate the potent political import of prescription drug prices as the U.S. approaches the 2020 Presidential election.

article thumbnail

How Will the “New” Health Economy Fare in a Macro-Economic Downturn?

Health Populi

I had asked some years ago, “what is a pharmacy” anymore, when CVS Pharmacy dropped tobacco from its SKUs and aisles in February 2014, rebranding as CVS Health; and, when Amazon purchased PillPack in June 2018. ” Dr. Cosgrove based that sobering forecast due to changes in the U.S.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

In U.S. Health Care, It’s Still the Prices, Stupid – But Transparency and Consumer Behavior Aren’t Working As Planned

Health Populi

As the Harvard Chan-POLITICO study points out, prescription drug costs are top-of-mind for health consumers in America. A second story involves a more mainstream drug: insulin, which is used by millions of people with diabetes. The therapy treats thalassemia, a genetic disease that affects 1,000 people in the U.S.

article thumbnail

Prescription Drug Costs In America Through the Patient Lens, via IQVIA, GoodRx and a New $2 Million Therapy

Health Populi

prescriptions per person in 2018, two in three of which treated chronic conditions. the annual review of prescription drug supply, demand and Rx pricing dynamics from the IQVIA Institute for Human Data Science. prescription drug market might look like five years from now. Americans consumed 17.6

article thumbnail

The 2020 Social Determinants of Health: Connectivity, Art, Air and Love

Health Populi

Humana’s Bold Goal initiative targeting Medicare Advantage enrollees. Even seemingly popular plan ideas like prescription drug pricing and coverage for pre-existing conditions can’t get traction in Congress or through the White House’s executive pen.

article thumbnail

The Gap Between the Trump Administration’s Promise of Reducing Rx Costs for Consumers and What People Really Want

Health Populi

This is what happened to pharma stock prices on Friday after President Trump and Secretary of Health and Human Services Alex Azar outlined their new policies focusing on prescription drug prices. Smart Pharmaceuticals Index (NQSSPH) from May 11, 2018, the date when POTUS and Secretary Azar made their announcement.

article thumbnail

Rx 2018: A New Era of Specialty Drugs, Telehealth, Mobile Apps and Value, IQVIA Reports

Health Populi

In 2018, spending on branded prescription drugs will fall in wealthy countries, while spending on specialty drugs will increase, resulting in flat medicines spending. Specifically, $19 billion worth of biotech spending will find biosimilar competition starting in 2018 for the first time. In the U.S.,